What should I do if I have a family history of breast cancer?

Written by: Dr Shiroma De Silva-Minor
Published: | Updated: 04/04/2024
Edited by: Conor Lynch

In this article below, revered consultant medical and clinical oncologist, Dr Shiroma De Silva-Minor, offers expert pieces of advice to patients who have a family history of breast cancer.

What should I do if I have a family history of breast cancer?

If you have a family history of breast cancer, as a breast oncologist, I recommend taking proactive steps to manage your risk. Here are some important considerations:

 

  1. Understand your risk: It is important to know your family history of cancers and understand your personal risk. If you have a first-degree relative (mother, sister, daughter) who has been diagnosed with breast cancer, your risk is higher than the general population. Consider other cancers that can also be related to genetic mutations, such as ovarian cancer (including fallopian tube and primary peritoneal cancers), male breast cancer, and to a lesser extent other cancers such as prostate, pancreatic cancer, and melanoma. Remember, cancer genes can affect both men and women so it is important to consider the risk for male relatives as well.
  2. Early detection: Early detection is key to successful treatment of breast cancer. It is important to start screening mammograms earlier and more frequently than the recommended age of 50 for the general population. It may be appropriate for women with a family history of breast cancer to begin mammogram screening 10 years or more before standard screening age, depending on the level of risk. Find out more information on familial breast cancer. (www.nice.org.uk – will be hyperlinked in article)
  3. Genetic testing: Genetic testing can help determine if you carry an inherited gene mutation that increases your risk of breast cancer. If you test positive for a gene mutation, you can take steps to manage your risk, such as increased surveillance, chemoprevention, or risk reductive surgery.
  4. Lifestyle changes: While family history cannot be changed, making lifestyle changes can help lower your risk of breast cancer. This includes maintaining a healthy weight (BMI under 25), healthy eating (limiting processed foods and refined sugars and carbohydrates), exercising regularly, limiting alcohol intake, and avoiding tobacco.
  5. Consult with a specialist: If you have a family history of breast cancer, consult a breast cancer specialist to assess your risk, whether genetic testing should be under taken and for personalised risk-management strategies.

 

It is important to remember that only five to 10 per cent of all breast cancers are hereditary, and even if a genetic mutation is identified, it does not mean that cancer is an inevitability. Knowledge is power, allows you options, and arms you with the information you need to make the right decisions for you and your family.

 

If you’d like to make an appointment today with Dr Shiroma De Silva-Minor, head over to her Top Doctors profile to do just that.

By Dr Shiroma De Silva-Minor
Medical oncology

Dr Shiroma De Silva-Minor is an accomplished and experienced consultant breast oncologist who specialises in breast cancer (both male and female), breast screening, chemotherapy, radiotherapy, immunotherapy, intraoperative radiation therapy, inflammatory breast cancers, HER2 positive disease, triple-negative breast cancers and breast cancer in pregnancy.

Dr De Silva-Minor oversees the entire (non-surgical) breast cancer pathway so she can advise on all aspects of treatment, including genetic counselling and testing, systemic (chemo) therapy, radiotherapy, and lifestyle factors in optimising health and minimising disease recurrence. Dr De Silva-Minor is currently practising privately, at the London-based Cromwell Hospital, as well as at GenesisCare Oxford, at The Chiltern Hospital, and as an NHS Consultant at the Oxford University Hospitals NHS Foundation Trust, Oxford.

Dr De Silva-Minor, whose clinical expertise is in the treatment of early and recurrent breast cancer, notably obtained her first medical qualification in 1995, with her medical doctorate from the prestigious Cardiff-based University of Wales College of Medicine. In 1999, Dr De Silva-Minor was awarded the membership of the Royal College of Physicians (UK). Dr De Silva-Minor pursued her specialist oncology training at several centres of oncological excellence in London, including The Middlesex Hospital, The Royal Free Hospital, as well as The Royal Marsden Hospital, amongst others.

In 2003, Dr De Silva-Minor was awarded the fellowship of the Royal College of Radiologists and was also recognised as a clinical oncology specialist on the General Medical Council's register in 2007. Dr De Silva-Minor has been a consultant oncologist since 2007 and was appointed as a substantive consultant oncologist by the Oxford University Hospitals NHS Foundation Trust in 2008.

Dr De Silva-Minor has published extensively in peer-reviewed journals. During a fellowship in head and neck radiation oncology at The Princess Margaret Hospital in Toronto, Canada, Dr De Silva-Minor was awarded the Prize for Academic Excellence by the Princess Margaret Hospital and the University of Toronto for her research into the use of PETCT scans (Positron Emission Tomography) when identifying head and neck tumours for treatment with radiotherapy. Dr De Silva-Minor is a member of the breast cancer expert panel for the National Institute of Health and Clinical Excellence (NICE), updating clinical guidelines on breast cancer management.

Dr De Silva-Minor is also collaborating on a metanalysis with the Early Breast Cancer Trialists' Collaborative Group (EBCTCG) to bring together the research on radiotherapy clinical trials to better understand how to optimally treat breast cancer patients with radiotherapy. Dr De Silva-Minor is a member of the Advisory Board on Cancer in Pregnancy (ABCIP), an international panel of experts in managing breast cancer in pregnancy. Dr De Silva-Minor is a passionate advocate for empowering her patients to be involved in their management decisions. Treatment is completely bespoke to individual patients, their specific tumour subtype, taking into consideration the individual's beliefs, wishes and personal circumstances.

View Profile

Overall assessment of their patients


  • Related procedures
  • Prostate cancer
    Breast cancer
    Bone cancer
    Nervous system malformations
    Brain tumour
    Bone marrow cancers
    Testicular cancer
    Thyroid cancer
    Adrenal glands cancer
    Neuro-oncology
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.